FOREIGN TRADE NOTIFICATION
2021-22

Notification No. 56/2015-2020, Dated: 24th February, 2022

Government of India

Ministry of Commerce & Industry

Department of Commerce

Directorate General of Foreign Trade

Subject: Amendment in Export Policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) - regarding

In exercise of powers conferred by Section 3 read with Section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes following amendment in Notification No. 08/2015-20 dated 14.06.2021, Notification No. 07/2015-20 dated 01.06.2021 and Notification No. 50/2015-20 dated 10.01.2022 related to export of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API):

S.No	ITC HS Codes	Description	Existing Policy	Revised Policy
207AA	Ex 293499 Ex 300490	Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API)	Restricted	Free
207AB	Ex 30049029 Ex 30049099	Amphotericin - B Injections	Restricted	Free
207 AE	Ex 2942 Ex 3001 Ex 3002	Enoxaparin (Formulation and API)	Restricted	Free
207 AF	Ex 3002	Intra-Venous Immunoglobulin (IVIG) (Formulation and API)	Restricted	Free

2. Effect of this Notification:

The export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API), Amphotericin - B injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under HS code as mentioned above or falling under any other HS code has been made 'Free' with immediate effect.

(Santosh Kumar Sarangi)

Director General of Foreign Trade

Ex-Officio Additional Secretary, Gol

(Issued from F. No. 01/91/180/24/AM22/EC /E-27724)